Similar articles

• The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.

  Takagi LR, Gulling EA, O'Leary JA. Takagi LR, et al. J Med Assoc Ga. 1978 Aug;67(8):644-5. J Med Assoc Ga. 1978. PMID: 574529 No abstract available.
• Vaginal prostaglandin E2 in the management of fetal intrauterine death.

  Southern EM, Gutknecht GD, Mohberg NR, Edelman DA. Southern EM, et al. Br J Obstet Gynaecol. 1978 Jun;85(6):437-41. doi: 10.1111/j.1471-0528.1978.tb14910.x. Br J Obstet Gynaecol. 1978. PMID: 350261 Clinical Trial.
• Prostaglandins for inducing labor and abortion.

  [No authors listed] [No authors listed] Drug Ther Bull. 1973 May 25;11(11):41-3. Drug Ther Bull. 1973. PMID: 4728968 No abstract available.
• The prostaglandins: their significance in clinical practice.

  Nakano J. Nakano J. Med Times. 1974 Dec;102(12):47-58. Med Times. 1974. PMID: 4373633 Review. No abstract available.
• Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.

  Johansson C, Kollberg B. Johansson C, et al. Scand J Gastroenterol Suppl. 1980;58:93-7. Scand J Gastroenterol Suppl. 1980. PMID: 6988944 Review. No abstract available.